Maternal and fetal outcome in women with antiphospholipid syndrome: a three-year observational study (vol 29, pg 4015, 2016)

被引：0

|

作者：

Rezk, Mohamed

Dawood, Ragab

Badr, Hassan

机构：

来源：

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE | 2022年 / 35卷 / 24期

关键词：

D O I：

10.1080/14767058.2022.2110365

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

收藏

页码：4838 / 4838

页数：1

相关论文

共 50 条

[41] Comparative study on maternal and fetal outcome in pregnant women with rheumatic heart disease and severe mitral stenosis undergoing percutaneous balloon mitral valvotomy before or during pregnancy (vol 70, pg 685, 2018)
Sharma, J. B.
Yadav, Vikas
Mishra, S.
Kriplani, A.
Bhatla, Neerja
Kachhawa, Garima
Kumari, Rajesh
Toshayan, Varnit
INDIAN HEART JOURNAL, 2021, 73 (01) : 139 - 139
[42] The effectiveness of the peer delivered Thinking Healthy Plus (THPP+) Programme for maternal depression and child socio-emotional development in Pakistan: study protocol for A three-year cluster randomized controlled trial (vol 17, 442, 2016)
Turner, Elizabeth L.
Sikander, Siham
Bangash, Omer
Zaidi, Ahmed
Bates, Lisa
Gallis, John
Ganga, Nima
O'Donnell, Karen
Rahman, Atif
Maselko, Joanna
TRIALS, 2017, 18
[43] Examining bidirectional relationships between parenting and child maladjustment in youth with autism spectrum disorder: A 9-year longitudinal study (vol 29, pg 1199, 2016)
Dieleman, Lisa M.
De Pauw, Sarah S. W.
Soenens, Bart
Beyers, Wim
Prinzie, Peter
DEVELOPMENT AND PSYCHOPATHOLOGY, 2017, 29 (04) : 1513 - 1514
[44] RETRACTION: Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome (Retraction of Vol 132, Pg 219, 2016)
Ismail, A. M.
Hamed, A. H.
Saso, S.
Abu-Elhasan, A. M.
Abu-Elghar, M. M.
Abdelmeged, A. N.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 158 (02) : 497 - 497
[45] The cardiovascular risk of young women with polycystic ovary syndrome:: An observational, analytical, prospective case-control study (vol 89, pg 3696, 2004)
Orio, F
Palomba, S
Spinelli, L
Cascella, T
Tauchmanovà, L
Zullo, F
Lombardi, G
Colao, A
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5621 - 5621
[46] Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study (vol 11, e0167036, 2016)
Li, Hui
Li, Lin
Gu, Jian
Li, Yu
Chen, Xiaoli
Yang, Dongzi
PLOS ONE, 2017, 12 (04):
[47] Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients.(vol 5, pg 2521, 2005)
Vitko, S
Margreiter, R
Weimar, W
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) : 243 - 243
[48] Hepatic markers and development of type 2 diabetes in middle aged men and women:: a three-year follow-up study -: The DESIR study (Data from an Epidemiological Study on the Insulin Resistance syndrome)
André, P
Balkau, B
Born, C
Royer, B
Wilpart, E
Charles, MA
Eschwège, E
DIABETES & METABOLISM, 2005, 31 (06) : 542 - 550
[49] Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study (vol 386, pg 2089, 2015)
Sovio, U.
White, I. R.
Dacey, A.
Pasupathy, D.
Smith, G. C. S.
LANCET, 2015, 386 (10008): : 2058 - 2058
[50] Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis (vol 122, pg 4047, 2013)
Cervantes, F.
Vannucchi, A. M.
Kiladjian, J-J
BLOOD, 2016, 128 (25) : 3013 - 3013

← 1 2 3 4 5 →